HMB-002 (Part B) for von willebrand disease, type 3

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Jan 2025: Trial registered, NCT06754852
  2. 6 Feb 2025: Trial started, NCT06754852

The trials

NCT06754852: A Study Assessing HMB-002 in Participants With Von Willebrand Disease

State
Under way
Phase
Phase 1 and Phase 2
People
108 planned
Started
6 Feb 2025
Primary completion
Jul 2027
Arms
Part B Multiple Dose Assessment
Results
None posted
  1. 1 Jan 2025: Trial registered
  2. 6 Feb 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.